An evaluation of human papillomavirus testing for intermediate- and high-risk types as triage before colposcopy

https://doi.org/10.1016/0002-9378(95)91473-0Get rights and content

Abstract

OBJECTIVE: Our purpose was to evaluate the role of testing for intermediate- and high-risk human papillomavirus by use of a hybrid capture technique for predicting which patients with abnormal Papanicolaou smears are most likely to have squamous intraepithelial lesions or cancer.

STUDY DESIGN: Cervical cytologic studies, hybrid capture tests, and colposcopically directed biopsies were performed on 311 women referred to the colposcopy clinics with abnormal cytologic study results.

RESULTS: There was a highly significant correlation (p < 0.0001) between a positive human papillomavirus test and the finding of squamous intraepithelial lesions or invasive cancer. The sensitivity of human papillomavirus testing to detect high-grade squamous intraepithelial lesions was 74% when it was used alone and increased to 91% when coupled with abnormal cytologic study results of low- or high-grade squamous intraepithelial lesions or cancer. In 44 women with atypical squamous cells of undetermined significance on cytologic study, human papillomavirus testing identified six of 10 who had high-grade squamous intraepithelial lesions. For the 96 patients with low-grade squamous intraepithelial lesions, human papillomavirus testing was successful in identifying 29 of the 37 with high-grade squamous intraepithelial lesions (sensitivity 0.76).

CONCLUSION: Testing for intermediate- and high-risk human papillomavirus types by hybrid capture improves the detection of high-grade squamous intraepithelial lesions in women with atypical squamous cells of undetermined significance and low-grade squamous intraepithelial lesions over cytologic study used alone.

References (17)

  • JA Carmichael et al.

    Cervical dysplasia and human papillomavirus

    Am J Obstet Gynecol

    (1989)
  • MJ Campion et al.

    Progressive potential of mild cervical atypia: prospective cytological, colposcopic, and virological study

    Lancet

    (1986)
  • National Cancer Institute Workshop

    The 1988 Bethesda system for reporting cervical/vaginal cytologic diagnoses

    JAMA

    (1989)
  • N August

    Cervicography for evaluating the atypical Papanicolaou smear

    J Reprod Med

    (1991)
  • M Borst et al.

    HPV screening for women with atypical Pap smears

    J Reprod Med

    (1991)
  • AG Pearlstone et al.

    High rates of atypical cervical cytology: occurrence and clinical significance

    Obstet Gynecol

    (1992)
  • K Nasiell et al.

    Behavior of mild cervical dysplasia during long-term follow-up

    Obstet Gynecol

    (1986)
  • MH Schiffman

    Recent progress in defining the epidemiology of human papillomavirus infection and cervical neoplasia

    J Natl Cancer Inst

    (1992)
There are more references available in the full text version of this article.

Cited by (137)

  • Preinvasive Disease of the Cervix

    2012, Clinical Gynecologic Oncology: Eighth Edition
  • Screening properties of human papillomavirus testing for predicting cervical intraepithelial neoplasia in atypical squamous cells of undetermined significance and low-grade squamous intraepithelial lesion smears: a prospective study

    2009, Annals of Diagnostic Pathology
    Citation Excerpt :

    However, in other study reporting the highest sensitivity, the positive predictive value ranged from 17.3% to 28.3% and the specificity from 24.2% to 66.8% [17]. In the study reported by Hatch et al [27], the sensitivity for predicting the presence of grade 2 or 3 CIN, in patients with Papanicolaou tests reported as LSIL, was found to be 76%. In patients with Papanicolaou tests reported as ASCUS, the sensitivity was 60%; specificity, 68%; and positive predictive value, 35%.

  • Preinvasive Disease of the Cervix

    2007, Clinical Gynecologic Oncology
View all citing articles on Scopus

Presented by invitation at the Thirteenth Annual Meeting of the American Gynecological and Obstetricial Society, Hot Springs, Virginia, September 8–10, 1994.

View full text